Walleye Capital LLC Intellia Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $475,252 - $659,376	-24,100 Reduced 19.82%	97,500 $2 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $2 Million - $2.72 Million	100,100 Added 465.58%	121,600 $2.72 Million
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $102,426 - $141,040	-4,300 Reduced 16.67%	21,500 $591,000
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $310,344 - $433,356	13,400 Added 108.06%	25,800 $786,000
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $183,396 - $265,524	5,800 Added 87.88%	12,400 $392,000
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $20,748 - $27,618	-600 Reduced 8.33%	6,600 $269,000
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $169,830 - $228,582	5,100 Added 242.86%	7,200 $268,000
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $9,963 - $18,807	-300 Reduced 12.5%	2,100 $73,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $129,408 - $172,080	2,400 New	2,400 $134,000
Q2 2020 Aug 14, 2020	SELL	$11.14 - $22.87 $113,628 - $233,274	-10,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.44 - $15.58 $115,168 - $190,076	-12,200 Reduced 54.46%	10,200 $125,000
Q4 2019 Feb 14, 2020	BUY	$10.43 - $17.67 $113,687 - $192,603	10,900 Added 94.78%	22,400 $329,000
Q3 2019 Nov 14, 2019	SELL	$13.07 - $18.51 $26,140 - $37,020	-2,000 Reduced 14.81%	11,500 $154,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $111,040 - $147,280	8,000 Added 145.45%	13,500 $221,000
Q1 2019 May 15, 2019	BUY	$12.79 - $17.62 $70,345 - $96,910	5,500 New	5,500 $94,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.